2008
DOI: 10.1583/07-2286.1
|View full text |Cite
|
Sign up to set email alerts
|

Thoracic Aortic Endografting in Patients With Connective Tissue Diseases

Abstract: TEVAR in patients with connective tissue diseases is feasible but still questionable regarding their young age and the rates of endoleaks and reintervention due to disease progression. Close surveillance is mandatory. Low morbidity and mortality rates may justify TEVAR in emergencies as a "bridging" method.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
50
0
1

Year Published

2010
2010
2020
2020

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 96 publications
(57 citation statements)
references
References 21 publications
6
50
0
1
Order By: Relevance
“…19 In patients with connective tissue disease, high rates of endoleaks and reinterventions after TEVAR are reported. 20 In this cohort of patients, where a certain wall weakness exists eo ipso, early structural wall alterations after TEVAR (i.e., within landing zones) may be especially unfavorable. Additionally, we hypothesize that if open repair after TEVAR becomes necessary during the first days after stent implantation, the weakened aortic wall may make a stable anastomosis difficult.…”
Section: Discussionmentioning
confidence: 92%
“…19 In patients with connective tissue disease, high rates of endoleaks and reinterventions after TEVAR are reported. 20 In this cohort of patients, where a certain wall weakness exists eo ipso, early structural wall alterations after TEVAR (i.e., within landing zones) may be especially unfavorable. Additionally, we hypothesize that if open repair after TEVAR becomes necessary during the first days after stent implantation, the weakened aortic wall may make a stable anastomosis difficult.…”
Section: Discussionmentioning
confidence: 92%
“…Such techniques assume constant censoring, and also combine what can be a rather heterogenous patient cohort. Finally, while the majority of studies in the present review were performed at centers where there was no endovascular alternative, the preference of TEVAR as the first-line surgical treatment in some centers has relegated open surgery for those with connective tissue or extensive disease, and those unsuitable for endovascular intervention (33,35,49).…”
Section: Discussionmentioning
confidence: 99%
“…The connective tissue disorders (CTDs), such as Marfan syndrome, are recognized as a poor indication for TEVAR. [17][18][19] Furthermore, dynamic interactions between endograft and landing zone may play a role in development of a RTAD, especially in ''zone 0.'' A continuous motion resulting from its attachment to the beating heart is specific of the ascending aorta, including both radial expansion-contraction and wall translational motion.…”
Section: Discussionmentioning
confidence: 99%